Aggressive Mature (CD20 ) B-cell Lymphoma
Showing 9976 - 10000 of >10,000
Crizotinb or Standard Chemotherapy in Met Exon 14 Skipping
Recruiting
- Non-small Cell Lung Cancer
-
Changsha, Hunan, ChinaYongchang Zhang
Mar 1, 2022
Influenza-like Illness Trial in Zagazig (Biobran/MGN-3, Placebo)
Completed
- Influenza-like Illness
- Biobran/MGN-3
- Placebo
-
Zagazig, Sharkia, EgyptDepartment of Community Medicine and Public Health, Faculty of M
Nov 20, 2020
Recurrent Head Neck Cancer, Metastatic Head Neck Cancer Trial (Pembrolizumab, Cisplatin, Carboplatin)
Active, not recruiting
- Recurrent Head and Neck Cancer
- Metastatic Head and Neck Cancer
- Pembrolizumab
- +4 more
- (no location specified)
Aug 18, 2022
Aging, Stress, Disease Risk Trial in San Francisco (Aerobic Training Intervention)
Completed
- Aging
- +2 more
- Aerobic Training Intervention
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jun 9, 2022
Hepatocellular Carcinoma Trial in Nanjing (Surufatinib)
Recruiting
- Hepatocellular Carcinoma
-
Nanjing, Jiangsu, ChinaNanjing Drum tower hospital
Apr 6, 2022
Sentinel Node Extended in Squamous Cell Vulvar Cancer
Recruiting
- Vulva Cancer
- Sentinel Lymph Node
- Sentinel node biopsy
-
Stockholm, Stockholms Lan, Sweden
- +3 more
Aug 17, 2022
Advances in Neuropsychological Diagnostics
Recruiting
- Cognitive Impairment
- +2 more
- Neuropsychological instruments
-
Milan, Lombardia, ItalyIstituto Auxologico Italiano IRCCS
Mar 20, 2023
Behavior, Health Trial in Danville (Contact information, Urgent care map, Self-triage chart)
Not yet recruiting
- Behavior, Health
- Contact information
- +2 more
-
Danville, PennsylvaniaGeisinger Clinic
Mar 29, 2023
Analgesia Trial in Damanhur (Dexmedetomidine Hydrochloride, Dexamethasone Phosphate)
Recruiting
- Analgesia
- Dexmedetomidine Hydrochloride
- Dexamethasone Phosphate
-
Damanhūr, El-Beheira, EgyptDamanhour Teaching Hospital
Mar 29, 2023
Advanced Hepatocellular Carcinoma Trial in Shenzhen (GPC3 CAR-T cells)
Recruiting
- Advanced Hepatocellular Carcinoma
- GPC3 CAR-T cells
-
Shenzhen, Guangdong, ChinaLi Yu
Nov 17, 2022
Refractory Differentiated Thyroid Gland Carcinoma, Refractory Thyroid Gland Follicular Carcinoma, Refractory Thyroid Gland
Completed
- Refractory Differentiated Thyroid Gland Carcinoma
- +4 more
- Cediranib
- +3 more
-
Duarte, California
- +32 more
Jun 24, 2021
Colorectal Adenomas Trial in Xi'an (100mg Berberine HCl, 300mg Berberine HCl, Placebo Oral Tablet)
Completed
- Colorectal Adenomas
- 100mg Berberine hydrochloride
- +2 more
-
Xi'an, Shaanxi, ChinaLi
Jul 24, 2022
Squamous Cell Carcinoma of Head and Neck Trial in Chapel Hill, Charleston (biological, drug, radiation)
Recruiting
- Squamous Cell Carcinoma of Head and Neck
- Pembrolizumab
- +3 more
-
Chapel Hill, North Carolina
- +1 more
Oct 25, 2022
Periodontal Health, Periodontitis Trial in Istanbul (Non-surgically performed scaling and root planing)
Completed
- Periodontal Health
- Periodontitis
- Non-surgically performed scaling and root planing
-
Istanbul, TurkeyMarmara University, Faculty of Dentistry, Department of Periodon
Aug 6, 2021
Histoplasmosis, AIDS Trial in Porto Alegre (single dose of L-AmB, 2 doses of L-AmB, 2 weeks of L-AmB)
Recruiting
- Histoplasmosis
- AIDS
- single dose of L-AmB
- +2 more
-
Porto Alegre, Rio Grande Do Sul, BrazilIrmandade da Santa Casa de Misericórdia de Porto Alegre
Jul 12, 2021
ACL Injury, Rehabilitation After ACL Reconstruction, Accelerated Protocol Trial in Gamasa (rehabilitation protocol)
Active, not recruiting
- ACL Injury
- +2 more
- rehabilitation protocol
-
Gamasa, Eldakahlyia, EgyptDelta university
Feb 8, 2023
Hemodialysis Complication Trial in Cairo (Aerobic pedaling exercise)
Recruiting
- Hemodialysis Complication
- Aerobic pedaling exercise
-
Cairo, Dokki, EgyptFaculty of physical therapy, cairo university
Feb 1, 2023
Infectious and Noninfectious Lung Diseases Following Allogeneic
Not yet recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 27, 2023
NSCLC Trial in United States (erlotinib, bemcentinib)
Completed
- Non-Small Cell Lung Cancer
-
Los Angeles, California
- +9 more
Aug 16, 2022
NSCLC Trial in Worldwide (Lazertinib, Amivantamab, Pemetrexed)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- Lazertinib
- +3 more
-
Phoenix, Arizona
- +303 more
Aug 17, 2022
HLH Trial in Beijing (Thiotepa)
Recruiting
- HLH
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
May 10, 2023
COVID-19 Pneumonia Trial in Worldwide (BDB-001 Injection, Conventional treatment)
Unknown status
- COVID-19 Pneumonia
- BDB-001 Injection
- Conventional treatment
-
Dhaka, Bangladesh
- +11 more
Dec 29, 2021
Back Pain Trial in Lahore (Cervicothoracic mobility program, Conventional Treatment)
Recruiting
- Back Pain
- Cervicothoracic mobility program
- Conventional Treatment
-
Lahore, PakistanRiphah Rehabilitation Center
May 31, 2022
Knee Osteoarthritis Trial in Nazareth (Standard treatment + Active B-Cure laser)
Recruiting
- Knee Osteoarthritis
- Standard treatment + Active B-Cure laser
-
Nazareth, IsraelHoly Family Hospital
May 26, 2022